Last updated 2026-07-20
- Raised Pre-Seed round led by Tal Ventures, Dec 2024
Total raised
—
Last: Undisclosed Round 2025-01
Stage
Pre-Seed
Founded
2022
Headcount
30
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
ActualSignal is an Israeli startup that has developed an AI-driven neurological care platform. The company's platform aims to improve the monitoring and management of chronic neurological conditions, particularly Parkinson's disease. It offers a care management platform with a patient-friendly smartphone app, advanced data analytics, and personalized neurological profiling. This enables healthcare providers and care organizations to detect early risks and enhance patient outcomes. The platform integrates computer vision and wearable data to generate new clinical insights for Parkinson's care. ActualSignal's mission is to transform patient care by merging clinical rigor with advanced technology.
Funding history · 1 round · — total
2024-12
Pre-Seed
Undisclosed
★ Tal Ventures★ RUNI Ventures★ I-NEXT Capital★ Unicorn Technologies★ Longevity Venture Partners
Headcount over time
From 10 (2024-03) to 13 (2026-03) · +3 (+30%) · 6 points · source: Finder history + radar grounding
Q&A
- What is ActualSignal's primary focus?
- ActualSignal focuses on a Parkinson's Care Management Platform, utilizing AI technology and a unique dataset to provide care management, a smartphone app for patients, and value-based care analytics for healthcare professionals.
- When was ActualSignal founded?
- ActualSignal was founded in September 2023.
- How many employees does ActualSignal currently have?
- ActualSignal has 11-50 employees.
- What is ActualSignal's current funding stage?
- ActualSignal is currently in the Pre-Seed funding stage.
- Which investors participated in ActualSignal's January 2025 funding round?
- In January 2025, ActualSignal's funding round included Tal Ventures.
- What is the current deployment status of ActualSignal's platform?
- ActualSignal's platform is currently deployed with over 150 Parkinson's patients across two Florida ACOs and two neurology clinics, generating more than 60,000 assessments.
- What technologies does ActualSignal utilize in its platform?
- ActualSignal utilizes Artificial Intelligence and Machine Learning technologies in its platform.
- What are the primary target customers for ActualSignal?
- ActualSignal's primary target customers include Healthcare & Life Sciences, Healthcare providers, Insurance Companies, and Patients.
Team · 2
Hanan Iserovich
Founder · CEO & Co-Founder
Sagi Horev
Founder · Co-Founder & CTO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesPatientsProviders
Business model
B2B
Highlights
Verified
Tags
digital-healthcarecognitive-trainingalzheimers-diseasee-healthneurologyparkinsonneurosciencestrokepatient-carebrain-disorderchronic-deseasesremote-monitoringdiagnostics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | actualsignal.com/ |
|---|---|
| linkedin.com/company/87415885 |
Identifiers & details
| Legal name | ActualSignal Ltd. |
|---|---|
| Founded | 2022 |
| Employees (exact) | 30 |
| Offices | New York |
Radar intelligence
App Store
| App | Rating | Ratings |
|---|---|---|
| ActualSignal | 5 |
Web history (Wayback)
| Domain | actualsignal.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516874690 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2023-09-26 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Active charges / liens | 0 |
| Registry events | 1 — violation (1) |
| Registered address | שדרות רוטשילד 45 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |